Apfelbacher CJ, Heinl D, Prinsen CA et al. Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review. Systematic Reviews 2015; 4: 48.
Boers M, Kirwan JR, Wells G et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. Journal of Clinical Epidemiology 2014; 67: 745-53.
Heinl D, Prinsen CA, Deckert S et al. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review. Allergy 2015; 13 Nov, epub. doi: 10.1111/all.12806.
Kirwan JR, Boers M, Hewlett S et al. Updating the OMERACT filter: core areas as a basis for defining core outcome sets. Journal of Rheumatology 2014; 41: 994-9.
Moher D, Liberati A, Tetzlaff J et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine 2009; 6: e1000097.
Mokkink LB, Terwee CB, Knol DL et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Medical Research Methodology 2010; 10: 22.
Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality of Life Research 2010; 19: 539-49.
Schmitt J, Apfelbacher C, Spuls PI et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. Journal of Investigative Dermatology 2015; 135: 24-30.
Schmitt J, Langan S, Stamm T et al. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. Journal of Investigative Dermatology 2011; 131: 623-30.
Tan, J., et al. Acne severity grading: Determining essential clinical components and features using a Delphi consensus. J Am Acad Dermatol 2012; 67(2):187-193.
Williamson PR, Altman DG, Blazeby JM et al. Developing core outcome sets for clinical trials: issues to consider. Trials 2012; 13: 132.